Bank of America’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Buy |
67,978
+49,653
| +271% | +$1.46M | ﹤0.01% | 4008 |
|
|
2025
Q1 | $471K | Sell |
18,325
-19,921
| -52% | -$512K | ﹤0.01% | 4760 |
|
|
2024
Q4 | $1.1M | Buy |
38,246
+18,395
| +93% | +$531K | ﹤0.01% | 4174 |
|
|
2024
Q3 | $471K | Buy |
19,851
+3,143
| +19% | +$74.6K | ﹤0.01% | 4691 |
|
|
2024
Q2 | $289K | Buy |
16,708
+12,781
| +325% | +$221K | ﹤0.01% | 4892 |
|
|
2024
Q1 | $87.7K | Sell |
3,927
-5,038
| -56% | -$112K | ﹤0.01% | 5446 |
|
|
2023
Q4 | $164K | Buy |
8,965
+319
| +4% | +$5.85K | ﹤0.01% | 5269 |
|
|
2023
Q3 | $150K | Sell |
8,646
-701
| -7% | -$12.2K | ﹤0.01% | 5195 |
|
|
2023
Q2 | $170K | Sell |
9,347
-1,502
| -14% | -$27.3K | ﹤0.01% | 5114 |
|
|
2023
Q1 | $186K | Buy |
10,849
+3,343
| +45% | +$57.3K | ﹤0.01% | 5179 |
|
|
2022
Q4 | $174K | Buy |
7,506
+2,114
| +39% | +$49.1K | ﹤0.01% | 5252 |
|
|
2022
Q3 | $120K | Buy |
5,392
+125
| +2% | +$2.78K | ﹤0.01% | 5443 |
|
|
2022
Q2 | $101K | Sell |
5,267
-3,906
| -43% | -$74.9K | ﹤0.01% | 5681 |
|
|
2022
Q1 | $328K | Sell |
9,173
-297
| -3% | -$10.6K | ﹤0.01% | 5386 |
|
|
2021
Q4 | $824K | Buy |
9,470
+5,111
| +117% | +$445K | ﹤0.01% | 4727 |
|
|
2021
Q3 | $500K | Buy |
4,359
+4,330
| +14,931% | +$497K | ﹤0.01% | 4848 |
|
|
2021
Q2 | $6K | Buy |
+29
| New | +$6K | ﹤0.01% | 6580 |
|